Eosinophilic Gastrointestinal Disorders Registry

Part of paid clinical trials in Chicago, Illinois.

Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Study ID
NCT05199532
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
1 Year - 25 Years
Healthy Volunteers
Not accepted

Study Details

The purpose of this study is to learn more about Eosinophilic Gastrointestinal Disorders (EGIDs). With this registry we hope to find out more about the symptoms that patients have during their treatment, the quality of life they have with the diagnosis, what the disease looks like throughout the different treatment methods, and if there is a connection between EGIDs and connective tissue disorders. The goal of this study is to be able to better understand EGIDs and use information gained from all the information collected on this study for more precise treatments in the future. We want to create a large collection of samples, called a biorepository, to learn the most about EGIDs as possible. When the samples are collected, which will occur at procedures directed by your child's doctor as part of their standard of care, they will be stored for an unlimited amount of time to perform experiments on these samples and to gather information about EGIDs

Key Dates

Start date
Dec 18, 2020
Status verified
Mar 2026
Primary completion
Nov 30, 2030
Completion
Dec 31, 2035

Study Design

Enrollment
500 participants (estimated)

Primary Outcome Measure

Clinical/Patient-Reported Measures [ Time Frame: through study completion, an average of 6 months to 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Ann & Robert H Lurie Children's Hospital of ChicagoChicagoIllinois60611
Zeinab Dehghani, MD
312-227-4656
Angela Anthony
312-227-4559
Joshua B Wechsler, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Chicago, IL

Related Studies